Jenapharm Report issue

For profit Phase 2
Founded: Jena Germany (1950)
Status: Acquired by Schering AG (1990) → now Bayer (2009)

Organization Overview

First Clinical Trial
2002
NCT00160433
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2002

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Jenapharm GmbH & Co. KG

Active Ingredients

Drugs in Phase 2 Trials (1)

asoprisnil (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Endometriosis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1